U.S. consumer prices increased in January by the most in nearly a year and a half, reinforcing the Fed’s message that it was ...
The S&P 500 ended down on Wednesday after a hotter-than-expected US inflation reading added to worries that the Federal ...
The S&P 500 dipped on Wednesday as a hotter-than-expected U.S. inflation reading added to worries that the Federal Reserve ...
The Handmaid’s Tale will release its sixth and final season in April. The final chapter follows Elisabeth Moss’ June Osborne ...
US consumer prices saw their biggest jump in 18 months, backing the Federal Reserve’s stance on holding rates.
Compelling clinical results for GLPG5101 in three NHL indications underscore potential of innovative decentralized cell therapy platform to ...
U.S. consumer prices increased in January by the most in nearly a year and a half. The surge offered a cautionary note to Trump's push for tariffs.
Gilead reported Q4 adjusted EPS of $1.90, exceeding estimates, with HIV sales up 16%. The company raised guidance and expects a key HIV drug launch in 2025.
U.S. stocks pared early losses on Wednesday but remained mostly lower after inflation data came in hotter than expected, potentially complicating the Federal Reserve's job of returning inflation to ...
We think its portfolio and pipeline support a wide moat, and with the HCV market stabilizing, Gilead needs strong continued innovation in HIV, solid oncology pipeline data, and smart future ...
Big drug maker Gilead expects to take a billion-dollar hit this year via drug-pricing provisions in the Inflation Reduction ...
With Gilead Sciences' long-acting lenacapavir unlocking a reinvigorated focus on the pre-exposure prophylaxis (PrEP) market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results